Hutch News

Hutch News

Stories tagged 'head neck cancers'

Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


New integrated research center launches

Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents

Aug. 10, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Denise Galloway heads new collaborative center to research prevention and treatment of infection-related cancers

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 16, 2017

Dr. Eduardo Méndez has received a five-year, $2.2 million grant from the National Institutes of Health to develop the first targeted therapy that they hope will be effective for most patients with head and neck cancers.

View story >


Finding ways to deliver on the promise of precision oncology

‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients

March 31, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.

View story >


Nearly half of U.S. men actively infected with HPV, study finds

HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated

Jan. 19, 2017 | By Rachel Tompa / Fred Hutch News Service

HPV-linked cancers on the rise in men, but nearly nine in 10 vaccine-eligible men are unvaccinated, new research shows.

View story >


HPV vaccine boosts immune memory

A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection

Aug. 10, 2016 | By Sabrina Richards / Fred Hutch News Service

It’s long been known that the vaccine against the human papilloma virus offers protection when administered to those who’d never experienced HPV infection. But new research suggests the possibility that it could also help those who’d been previously infected to guard against re-infection, according to results recently published in EBioMedicine.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.